Seres Therapeutics, Inc.
MCRBBiotechnology
$1.95+8.94%As of Oct 29vs prior close
- Market cap
- $19.6M
- P/E (TTM)
- –
- From 52W high
- −93.19%
- EPS (LTM)
- -$2.45
- Revenue (LTM)
- $1.9M
- Net margin
- -1192.94%
- Dividend yield
- 0.00%
Nomior Score
0
Fragile PremiumBottom 1% of the scored universe
Growth16
Quality28
Value26
Momentum5
Resilience29
Growth
−30.83%revenue a year over 9 fiscal years
YE16 $21.8MLTM $1.9M
Connections
Revenue to profitQ2 YE26
The operating loss was 2890% of revenue.
Who owns it
1fund